Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study

Persistent educational and structural barriers continue to limit optimal biologic use despite formal availability, highlighting the need for targeted education, streamlined care pathways, and improved physician-patient communication to achieve equitable outcomes.